Portfolio company
ZoBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides fragment-based drug discovery services and biophysical technologies for pharmaceutical and biotechnology clients to identify and develop small molecule leads.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
X Chemrx
This company provides small molecule drug discovery services and screening technologies to biotechnology and pharmaceutical organisations.
ENZYMLOGIC
This company provides kinetic profiling assays and platforms to biotechnology and pharmaceutical organisations to facilitate drug discovery and lead optimisation.
CrystalsFirst GmbH
This company provides structural biology and AI-driven drug discovery services to pharmaceutical and biotechnology organisations for small-molecule development.
Prism BioLab
This company develops small molecule drug candidates using its proprietary protein-mimicry technology for pharmaceutical companies, biotechnology firms and researchers.
Orbit Discovery
The company provides a peptide display platform for biotechnology and pharmaceutical partners to identify and optimise lead compounds for novel therapeutic drug development.
48Hour Discovery
This company develops a peptide discovery platform and screening services for pharmaceutical and biotechnology organisations to accelerate drug development.
Hybrigenics
This company provides protein interaction screening services and nanobody selection to pharmaceutical, biotechnology, and academic researchers to support early-stage drug discovery.
AAX Biotech
This company develops antibody engineering technologies for epitope mapping and fragment stabilisation to support pharmaceutical and biotechnology firms in drug discovery.
